Transaction DateRecipientSharesTypePriceValue
24th November 2020Capital Managing Member Iv, Llc Avista100Open or private purchase$5.00$500.00
20th November 2020Capital Managing Member Iv, Llc Avista2,739Open or private purchase$4.99$13,670.62
17th November 2020Arthur S Leibowitz6,943Open or private purchase$3.25$22,564.75
17th November 2020Glenn H Nussdorf347,153Open or private purchase$3.25$1,128,247.25
17th November 2020Alan A. Ades347,153Open or private purchase$3.25$1,128,247.25
17th November 2020Glenn H Nussdorf486,000Open or private purchase$3.25$1,579,500.00
17th November 2020Alan A. Ades486,000Open or private purchase$3.25$1,579,500.00
22nd April 2020Wayne D Mackie18,564Grant/award etc.$0.00
22nd April 2020Joshua Alexander Tamaroff18,564Grant/award etc.$0.00
22nd April 2020Arthur S Leibowitz18,564Grant/award etc.$0.00
Organogenesis Holdings
Organogenesis Holdings logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

Organogenesis Holdings, Inc. focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

Ticker: ORGO
Sector: Finance
Industry: Financial Conglomerates
SEC Central Index Key (CIK): 1661181
Employees: 835
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags